Healthequity (HQY) Change in Receivables (2013 - 2026)

Healthequity's Change in Receivables history runs 14 years deep, the most recent figure standing at -$1.7 million for Q2 2026.

• On a quarterly basis, Change in Receivables rose 3.26% year-over-year to -$1.7 million in Q2 2026; TTM through Apr 2026 was $5.7 million, a 42.75% decrease from a year earlier, with the FY2026 full-year figure at $5.7 million, down 56.61% from the prior year.
• Change in Receivables slipped to -$1.7 million in Q2 2026 per HQY's latest filing, from $12.5 million in the prior quarter.
• Across five years, Change in Receivables topped out at $12.5 million in Q1 2026 and bottomed at -$5.8 million in Q3 2023.
• The 5-year median for Change in Receivables is $1.2 million (2022), against an average of $2.0 million.
• Biggest YoY gain for Change in Receivables was 1971.84% in 2022; the steepest drop was 400.0% in 2022.
• Year by year, Change in Receivables stood at -$2.7 million in 2022, then surged by 232.84% to $3.6 million in 2023, then slumped by 148.39% to -$1.7 million in 2024, then surged by 104.54% to $79000.0 in 2025, then plunged by 2243.04% to -$1.7 million in 2026.
• Per Business Quant, the three latest HQY Change in Receivables figures stand at -$1.7 million (Q2 2026), $12.5 million (Q1 2026), and $79000.0 (Q4 2025).